On February 14, President Vladimir Putin announced that Russian scientists are on the brink of creating vaccines for cancer, which could soon be accessible to patients. Speaking at a future technology symposium in Moscow, Putin stated that they are nearing the development of "cancer vaccines and immunomodulatory drugs of a new generation" and expressed hope that these treatments would soon be effectively utilized as individual therapy.
While Putin did not specify the types of cancer the vaccines would target or the method of administration, he highlighted the significant progress being made in this area. Several countries and companies are actively working on cancer vaccines, with the UK government collaborating with BioNTech to conduct clinical trials for personalized cancer treatments, aiming to benefit 10,000 patients by 2030.
Additionally, pharmaceutical companies Moderna and Merck & Co are in the process of developing an experimental cancer vaccine. A mid-stage study demonstrated that this vaccine reduced the chance of recurrence or death from melanoma, the most deadly form of skin cancer, by half after three years of treatment.
Currently, there are six licensed vaccines for human papillomaviruses (HPV) that can cause various cancers, including cervical cancer, according to the World Health Organization. There are also vaccines available for hepatitis B (HBV), which is linked to liver cancer.
No comments:
Post a Comment